Allurion Technologies (ALUR) Competitors $2.18 -0.06 (-2.68%) Closing price 03:59 PM EasternExtended Trading$2.21 +0.03 (+1.19%) As of 07:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALUR vs. INO, LUNG, TELA, SPAI, QTI, SRTS, PYPD, MDAI, CTCX, and ICCMShould you be buying Allurion Technologies stock or one of its competitors? The main competitors of Allurion Technologies include Inovio Pharmaceuticals (INO), Pulmonx (LUNG), TELA Bio (TELA), Safe Pro Group (SPAI), QT Imaging (QTI), Sensus Healthcare (SRTS), PolyPid (PYPD), Spectral AI (MDAI), Carmell (CTCX), and IceCure Medical (ICCM). These companies are all part of the "medical equipment" industry. Allurion Technologies vs. Its Competitors Inovio Pharmaceuticals Pulmonx TELA Bio Safe Pro Group QT Imaging Sensus Healthcare PolyPid Spectral AI Carmell IceCure Medical Allurion Technologies (NYSE:ALUR) and Inovio Pharmaceuticals (NASDAQ:INO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk. Is ALUR or INO more profitable? Inovio Pharmaceuticals has a net margin of 0.00% compared to Allurion Technologies' net margin of -158.30%. Allurion Technologies' return on equity of 0.00% beat Inovio Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Allurion Technologies-158.30% N/A -59.91% Inovio Pharmaceuticals N/A -163.32%-96.41% Does the media prefer ALUR or INO? In the previous week, Inovio Pharmaceuticals had 4 more articles in the media than Allurion Technologies. MarketBeat recorded 5 mentions for Inovio Pharmaceuticals and 1 mentions for Allurion Technologies. Inovio Pharmaceuticals' average media sentiment score of 1.03 beat Allurion Technologies' score of 0.67 indicating that Inovio Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Allurion Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inovio Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation and earnings, ALUR or INO? Allurion Technologies has higher revenue and earnings than Inovio Pharmaceuticals. Inovio Pharmaceuticals is trading at a lower price-to-earnings ratio than Allurion Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAllurion Technologies$32.11M0.51-$7.20M-$12.53-0.17Inovio Pharmaceuticals$220K492.75-$107.25M-$2.61-0.78 Do analysts prefer ALUR or INO? Allurion Technologies currently has a consensus target price of $22.83, suggesting a potential upside of 947.40%. Inovio Pharmaceuticals has a consensus target price of $8.80, suggesting a potential upside of 331.37%. Given Allurion Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Allurion Technologies is more favorable than Inovio Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Allurion Technologies 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.80Inovio Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Which has more risk & volatility, ALUR or INO? Allurion Technologies has a beta of -0.45, meaning that its share price is 145% less volatile than the S&P 500. Comparatively, Inovio Pharmaceuticals has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500. Do insiders & institutionals hold more shares of ALUR or INO? 21.4% of Allurion Technologies shares are owned by institutional investors. Comparatively, 26.8% of Inovio Pharmaceuticals shares are owned by institutional investors. 9.6% of Allurion Technologies shares are owned by company insiders. Comparatively, 2.3% of Inovio Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryAllurion Technologies beats Inovio Pharmaceuticals on 9 of the 17 factors compared between the two stocks. Get Allurion Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ALUR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALUR vs. The Competition Export to ExcelMetricAllurion TechnologiesMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$16.70M$10.78B$5.74B$21.17BDividend YieldN/A1.87%3.95%3.54%P/E Ratio-0.1721.6130.3328.99Price / Sales0.5131.64462.1154.60Price / CashN/A24.9137.7223.61Price / Book-0.253.529.775.33Net Income-$7.20M$210.11M$3.27B$995.89M7 Day Performance-3.33%8.52%3.95%2.56%1 Month Performance-28.17%12.73%3.81%2.81%1 Year Performance-87.18%-7.02%31.26%11.06% Allurion Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALURAllurion Technologies2.9511 of 5 stars$2.18-2.7%$22.83+947.4%-87.0%$16.70M$32.11M-0.17501Earnings ReportGap DownINOInovio Pharmaceuticals4.1738 of 5 stars$1.90+2.2%$8.80+363.2%-74.0%$68.21M$220K-0.73320Positive NewsGap UpLUNGPulmonx4.217 of 5 stars$1.60+2.6%$7.66+379.0%-77.8%$63.56M$83.79M-1.12250News CoverageTELATELA Bio3.1142 of 5 stars$1.70+7.6%$4.50+164.7%-38.2%$62.59M$69.30M-1.52120SPAISafe Pro Group0.9448 of 5 stars$4.06+5.7%$8.00+97.0%N/A$58.26M$2.17M-5.0711QTIQT ImagingN/A$2.03+1.5%N/A+219.0%$55.08M$4.00M0.00N/ANews CoverageSRTSSensus Healthcare2.3108 of 5 stars$3.31-1.2%$8.00+141.7%-52.4%$55.07M$41.81M-55.1740PYPDPolyPid2.5893 of 5 stars$3.51+1.7%$12.40+253.3%+1.5%$54.85MN/A-0.9280MDAISpectral AI3.0188 of 5 stars$2.12+0.5%$3.50+65.1%+36.2%$53.42M$29.58M-3.0783CTCXCarmellN/A$2.55+8.5%N/A+264.3%$53.31M$32.84K0.0014News CoverageICCMIceCure Medical1.8115 of 5 stars$0.89-0.7%$2.39+167.3%+40.8%$52.73M$3.29M-5.5860Gap Up Related Companies and Tools Related Companies Inovio Pharmaceuticals Competitors Pulmonx Competitors TELA Bio Competitors Safe Pro Group Competitors QT Imaging Competitors Sensus Healthcare Competitors PolyPid Competitors Spectral AI Competitors Carmell Competitors IceCure Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ALUR) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allurion Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allurion Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access